Skip to main content
Figure 3 | Stem Cell Research & Therapy

Figure 3

From: Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region

Figure 3

Differentiation abilities of human parthenogenetic embryonic stem cells. In vitro differentiated EBs displayed (A) positive AFP staining (endoderm), (B) positive SMA staining (mesoderm), (C) positive TUBULIN staining (ectoderm), and (D) expression of genes from endoderm (NF68KD), mesoderm (HBZ) and ectoderm (Albumin). Bar is 50 μm. (E) Efficiency of teratoma formation upon injection of human parthenogenetic embryonic stem cells into SCID mice; (F) neuro-ectoderm from ectoderm in teratoma; (G) cartilage from mesoderm in teratoma; (H) glandular tissue from endoderm in teratoma. Bar is 100 μm. EB, embryoid bodies; SCID, severe combined immunodeficiency.

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512